Acutus Medical, Inc. (AFIB) vs Biolase, Inc. (BIOLQ)
Acutus Medical, Inc. and Biolase, Inc. are both Medical Devices companies. Biolase, Inc. is the larger, with a market value of $2.3M against $1.7M — 1.4× the size. Acutus Medical, Inc. grew revenue faster over the last twelve months: 181.4% against −7.44%. Acutus Medical, Inc. has the higher net margin (−47.4% vs −71.8%) and the higher return on invested capital (−0.51% vs −109.5%). Across the 14 metrics below, Acutus Medical, Inc. leads on 7 and Biolase, Inc. on 7.
Valuation
Profitability
| Metric | AFIB | BIOLQ | Medical Devices median |
|---|---|---|---|
| Gross margin | 5.03% | 34.44% | 56.01% |
| Operating margin | (0.28%) | (29.37%) | (15.03%) |
| Net margin | (47.36%) | (71.75%) | (20.40%) |
| Free cash flow margin | (157.62%) | (28.55%) | (7.24%) |
| Return on equity | 153.11% | 1,349.30% | (15.32%) |
| Return on assets | (23.11%) | (100.09%) | (19.72%) |
| Return on invested capital | (0.51%) | (109.48%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack